Brown adipose tissue (BAT) plays a key role in energy expenditure and heat generation and is a promising target for diagnosing and treating obesity, diabetes and related metabolism disorders.
INTRODUCTION
Mammals utilize two types of adipose tissue for separate functions. White adipose tissue (WAT) stores excess triacylglycerols, performs endocrine signaling and represents 20-25% of human body mass.
1 Brown adipose tissue (BAT) confers adaptive thermogenesis and is 5% of the infant body mass. It is also found in adults but in much smaller quantities. 2, 3 BAT contains large amounts of mitochondria to dissipate chemical energy. Upon low temperature or pharmaceutical activation of the nervous system, BAT uses high levels of uncoupling protein-1 to generate heat instead of ATP production. The tissue is highly vascularized which promotes efficient heat transfer to the bloodstream and body temperature maintenance. 4 Medical imaging studies have shown that BAT mass is inversely correlated with body mass index and other obesity parameters in human adults. 3, 5 In recent years, multiple animal model studies and early stage clinical trials have explored strategies to activate and increase BAT mass. [6] [7] [8] [9] [10] Stimulation of BAT metabolism has been achieved through exercise, low temperature, and pharmaceutical agents. WAT can be transformed to BAT in a process known as "browning" using the same strategies. [11] [12] [13] [14] [15] [16] BAT mass has also been increased through transplantation with promising results. 17 Notably, BAT transplants have been reported to reverse type 1 diabetes by activating metabolism in the surrounding WAT. 18 Most recently a clonogenic population of BAT stem cells has been identified in adult humans and shown to functionally differentiate into metabolically active brown adipocytes. 19 Brown and beige adipocyte-specific cell surface markers have been discovered which may serve as tools for the selective delivery of drugs. 16, 20 Taken together, these emerging results suggest that BAT is a very promising imaging and therapeutic target for clinical treatment of obesity, diabetes, and related metabolic disorders. 21 Biomedical research on BAT and clinical translation is facilitated by non-invasive imaging methods that visualize BAT in living subjects. 22 The most common in vivo imaging technique uses 2-deoxy-2-[ 18 F]fluoro-D-glucose ( 18 F-FDG) for positron emission tomography/computed tomography (PET/CT) of tissues with enhanced metabolism such as activated BAT. 23 Several other nuclear probes have been investigated for BAT imaging and magnetic resonance imaging has also been utilized to monitor BAT morphology and chemical composition. [24] [25] [26] [27] [28] [29] [30] While useful for the detection of human BAT, which requires deep tissue imaging, these methods employ radioactivity or expensive instruments and they are not convenient for preclinical research using small animal models. In contrast, optical imaging of small animals is highly attractive because it is safe to perform, relatively inexpensive, and amenable to high throughput. 31 The shallow interscapular location of BAT in mice is perfectly suited for optical imaging protocols. 32 To date, only two fluorescent molecular probes for BAT imaging have been reported; (1) IR786, a lipophilic cationic near-infrared dye with affinity for mitochondria, 33 and (2) a fluorescently labeled nonapeptide that targets BAT vasculature. 34 Both fluorescent probes are notable as pioneering lead molecular structures, but they exhibit modest in vivo imaging performance.
The objective of this study was to find an effective method for optical imaging interscapular BAT in living mice. We were attracted to the lipophilic and uncharged squaraine rotaxane probe, SRFluor680, which exhibits extremely bright, deep-red fluorescence that enables high-sensitivity in vivo optical imaging. [35] [36] [37] [38] Cell microscopy studies have previously shown that SRFluor680 partitions rapidly and irreversibly into lipophilic intracellular sites such as lipid droplets and the endoplasmic reticulum. 36 Here, we report that treatment of living mice with a micellar formulation of SRFluor680 leads to extensive and selective probe accumulation in the interscapular BAT. Furthermore, SRFluor680 uptake is independent of mouse species and BAT metabolic state. A series of experimental results are described and used to rationalize the selective molecular imaging.
EXPERIMENTAL SECTION Ethics Statement
All animal experiments used protocols that were approved by the Notre Dame
Institutional Animal Care and Use Committee (Protocol Number: 13-10-1304).
Materials
SRFluor680 is commercially available (Molecular Targeting Technologies Inc) Absorption and fluorescence spectra of the micellar formulations were obtained in Phosphate Buffered Saline (PBS) (10 mM sodium phosphate, 150 mM sodium chloride, pH 7.4).
Transmission Electron Microscopy (TEM)
TEM images of the micelles were obtained using a FEI Titan 80-300 microscope at an acceleration voltage of 80 kV. The samples were prepared by drop-coating micellar SRFluor680
onto an amorphous carbon coated 300 square mesh nickel grid (Electron Microscopy Sciences)
followed by a single drop of 1% phosphotungstic acid (pH = 7) for negative staining. The grid was placed on filter paper to absorb excess solvent and dried overnight under vacuum.
Laser Transmission Spectroscopy (LTS)
The LTS instrumentation utilized for size measurements has been previously described. Unstained BAT slices were imaged using the orange and green filter sets, and the autofluorescence intensities were subtracted as background from the images of stained BAT.
Images were generated using NIS-Elements software (Nikon) and analyzed using ImageJ 1.40g.
Planar In Vivo Fluorescence Imaging
Athymic nude mice (strain NCr Foxn1nu, Taconic Farms) and immunocompetent SKH1 hairless mice (Charles River), Balb/C mice, and C57Bl/6 mice were housed at ambient room temperature and anesthetized with 2-3% isoflurane with an oxygen flow rate of 2 L/min. The mice were dosed with micellar SRFluor680, IR786, or Nile Red via the tail vein (100 µL).
Following dosing, the living SKH1 and nude mice were immediately imaged at various time points, whereas, the BalbC and C57Bl/6 mice were anesthetized by isoflurane inhalation (2-3%), euthanized by cervical dislocation and the skin removed prior to imaging to reduce scattering and imaging studies, the mice were anesthetized by isoflurane inhalation (2-3%) and euthanized by cervical dislocation.The major organs were dissected, placed on low reflectance paper and imaged as described above.
Ex Vivo Imaging of BAT Digestion
The adipose tissue digestion procedure was adapted from literature. 42 BAT was isolated from SKH1 mice (N=4) that had been treated with SRFluor680 (10 nmol) and sacrificed 6 hours after dosing. The adipose samples were separately washed with sterile PBS to remove debris and red blood cells, minced with scissors, and then placed into a 1. 
Fluorescence Image Analysis
The 16-bit TIFF images of each living mouse at the different time points were sequentially opened using the ImageJ 1.40g software and then converted to an image stack using the "convert images to stack" software command. The stack of images was background subtracted using the rolling ball algorithm (radius 500 pixels). Next, the image stack was set to the "Fire" fluorescence intensity scale (under "Lookup Tables" menu) which color-codes the fluorescence counts contained in each pixel. The stack of images was converted into a montage using the "convert stack to montage" command. A calibration bar was added to the montage using the "calibration bar" command, and the resulting image saved as a TIFF file.
Probe biodistribution was measured by Region of Interest (ROI) analysis of the fluorescent images of the dissected tissues. Using ImageJ 1.40g software, a free-hand ROI was drawn around each tissue image and the mean pixel intensity was measured. The biodistribution analyses assume that probe fluorescence from a specific organ suffers the same amount of signal attenuation and thus, the mean pixel intensities reflect relative probe concentration in the organ.
The tissue comparison in Figure 6 assumes that the BAT and WAT samples are equivalent tissue thicknesses, and that the mean pixel intensities reflect relative SRFluor680 concentration in the tissue.
Effect of BAT Activation on Probe Biodistribution
A cohort of SKH1 mice (N=6) were anesthetized with 2-3% isoflurane with an oxygen flow rate of 2 L/min. Half the mice were given an intraperitoneal dose of CL 316243 (1 mg/kg, 100 µL) and five minutes later all of the mice were injected intravenously with 15 nmol (150 µL)
of micellar SRFluor680 (in DPPE-PEG 2000 ) via the tail vein. One hour later, the mice were sacrificed and fluorescent probe biodistribution determined by imaging the excised tissues using the Xenogen IVIS Lumina and the image acquisition parameters described above. As a positive control, the experiment was repeated with micellar IR786 (15 nmol) instead of SRFluor680.
Multimodal PET/CT and Fluorescence/X-ray Imaging
A cohort of SKH1 hairless mice (N=4) were dosed with 15 nmol of micellar SRFluor680 
Statistical Analysis
Since the statistical analyses only compare two populations, the Student's t-test was applicable and the results are depicted as mean ± standard error of the mean.
RESULTS
SRFluor680 is a lipophilic, uncharged, water-insoluble, fluorescent dye with a permanently interlocked molecular structure ( Figure 1A ). Shown in Figure 1B Figure 2B ). The aqueous formulation was stable over a 6 hour period ( Figure S1 ). Essentially the same spectral and stability results were obtained using Cremophor El as the micellar vehicle.
Previous cell microscopy studies have demonstrated that SRFluor680 rapidly and irreversibly stains lipophilic intracellular sites without any evidence of cell toxicity. 36 Treatment of cultured mammalian cells with SRFluor680 solubilized in either DMSO or an aqueous dispersion of micelles produces essentially the same intense intracellular staining patterns.
Further evidence that SRFluor680 is able to translocate readily from the micellar vehicle into proximal lipophilic sites was gained by conducting experiments that monitored dye transfer into receiver liposomes using fluorescence resonance energy transfer (FRET). As illustrated in Figure   3A , FRET pair labeled micelles were created by encapsulating DiI and SRFluor680 into ( Figure S2 ). Each animal was imaged periodically using a whole-body, small animal imaging station that was configured for epifluorescence imaging with a deep-red filter set (ex: 615-665 nm, ex: 695-770 nm). A short while after dosage, there was clear evidence for selective SRFluor680 accumulation in the BAT deposits in the neck and interscapular area ( Figure 4A ). 43 In comparison, analogous longitudinal images of mice treated with IR786 or Nile Red showed little or no evidence for BAT targeting ( Figures 4B and 4C ).
These in vivo imaging results were confirmed with an ex vivo imaging analysis of organs taken from the animals after they were sacrificed at 6 hours after probe injection. The biodistribution data in Figure 5 shows that micellar SRFluor680 produced high probe To determine if SRFluor680 targeting to BAT was influenced by changes in metabolic activity, a cohort of SKH1 mice (N=3) was pretreated with CL 316243 (1 mg/kg), a β 3 adrenoceptor agonist that is known to activate BAT thermogenesis 45 . Five minutes later the mice were administered an intravenous dose of micellar SRFluor680 or IR786. The latter optical probe is known to increase accumulation in metabolically activated BAT and thus served as a positive control. 33 In each case, the animals were sacrificed at one hour after fluorescent probe injection and probe biodistribution in the excised tissues was determined. The data in Figure 10 show that BAT activation due to CL 316243 pretreatment produced the expected ~2-fold increase in BAT uptake of IR786 but did not alter the BAT uptake of SRFluor680. There was no difference in SRFluor680 biodistribution between the BAT activated and unactivated cohorts. 
DISCUSSION
Emerging research suggests that the amount BAT in a living subject and metabolic status of the BAT are important indicators and controllers of obesity and diabetes. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Imaging methods that can quantify BAT in humans are likely to be important for personal health and treatment.
Similarly, convenient high throughput methods that image BAT in small animals will facilitate preclinical research. Likely to be of great value are independent methods that non-invasively image BAT mass and BAT metabolic status. Quantification of BAT has been achieved using MRI techniques which exploit the greater water to fat ratio in BAT relative to WAT. [46] [47] [48] Unfortunately, accurate BAT volume can be difficult to measure with MRI when the adipose tissue signal contrast from surrounding internal structures is poor. 49 Although the metabolic probe 18 F-FDG can locate BAT, 50 it cannot easily measure BAT volume due to the fluctuating metabolic activity of BAT and the possibility of false-positive signals from other metabolically active tissues. 51, 52 PET and Single-Positron Emission Tomography (SPECT) using 18 Ffluorobenzyl triphenyl phosphonium, 26 123 I-metaiodobenzylguanidine 27 , 99mTc-tetrofosmin 28 , 99mTc-sestamibi, 29 and 99mTc-methoxyisobutylisonitrile 30 have all been used to detect the presence of BAT. However, nuclear and magnetic resonance imaging modalities are problematic for preclinical studies due to the expensive instrumentation and low throughput protocols. These imaging methods also require long scan times and large doses of anesthesia which are known to cause hypothermia and hypotension which may alter BAT metabolism. 53, 54 A recent international workshop concluded that new imaging approaches are needed to quantify BAT physiology and its association to metabolic syndrome. 22 The pharmaceutical challenge is to develop a molecular probe that will target the BAT and not the more abundant WAT. Two major differences between these tissue types are the extensive vasculature and high levels of mitochondria in BAT. Not surprisingly, one targeting strategy is to employ molecular probes that have selective affinity for mitochondria. An example of this approach is optical imaging using IR786, a cationic near-infrared fluorescent dye with affinity for mitochondria and BAT. 33 An alternative strategy is to target the BAT vasculature, and a recent investigation uncovered a unique peptide sequence with affinity for the vasculature endothelium of BAT. 34 The peptide was converted into a fluorescent probe that enabled optical imaging of BAT but relatively high probe dosages were required.
The in vivo imaging and biodistribution data in Figures 4-7 show that SRFluor680 is able to strongly accumulate within interscapular BAT with 3.5-fold selectively over the adjacent interscapular WAT. Furthermore, the SRFluor680 targets the adipocytes within the BAT ( Figure 9 ). Ex vivo tissue staining experiments show that the lipophilic SRFluor680 molecule has about the same inherent affinity for BAT and WAT ( Figure 8) ; thus, the in vivo selectivity for BAT must be due to a selective pharmacokinetic effect. There is no evidence that the SRFluor680 is targeting a protein biomarker in the BAT. In contrast, cell fluorescence microscopy and liposome translocation studies (Figure 3) show that SRFluor680 transfers spontaneously from micelles into nearby lipophilic receiver sites, in agreement with literature expectations. 55 Our Strong partitioning of SRFluor680 into the lipophilic adipocytes within BAT explains why the in vivo accumulation is independent of BAT metabolic status ( Figure 10) ; whereas, the observation of increased uptake of IR786 upon pharmacological activation of the BAT supports its known mitochondria targeting mechanism. 33 Together these results suggest a new dual probe molecular imaging paradigm that allows separate and independent non-invasive visualization of BAT mass and BAT metabolism in a living subject. A prototype demonstration of the concept is the set of multimodal mouse images in Figure 10 showing interscapular BAT mass reported by the optical probe (SRFluor680) and enhanced BAT metabolism reported by the PET agent ( 18 F-FDG).
Additional studies are needed to determine the sensitivity of this specific dual probe imaging protocol to changes in BAT mass and metabolic state.
While fluorescence imaging of BAT is not likely to be directly useful for clinical studies of humans, it may be a valuable technique for preclinical imaging studies of living mice because it is safe to perform (no ionizing radiation), relatively inexpensive, involves short scan times Furthermore, it is worth noting that squaraine rotaxane dyes have unusually high two-photon cross sections (up to 10,000 GM) so it is possible that SRFluor680 can be used for BAT imaging using two-photon illumination methods. 
